The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Certain illnesses common in older adults—such as sleep apnea, heart problems, or diabetes—disrupt rest. Additionally, several ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat ...

After announcing a $20 million funding round in June, the startup has set its sights on growing its customer-facing workforce ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Sleep apnea is a condition where breathing repeatedly stops or reduces during sleep, often due to airway obstruction. It ...

This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the signs are more subtle, research suggests as many as 90% of women who have ...

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

The sleep apnea detection feature that Apple's most recent Apple Watch models offer has expanded to several more countries in ...

If left untreated, obstructive sleep apnea raises the risk of hypertension, heart disease, type 2 diabetes, depression and even an early death, according to the American Academy of Sleep Medicine.